Recent literature shows that most practicing psychiatrists do not receive training in measurement-based care (MBC). Among the primary barriers to MBC implementation are the lack of formal training and curriculums. We present the first comprehensive MBC curriculum for use in adult psychiatric practice, and describe how the curriculum is adapted and implemented in psychiatry residency training programs.
Methods
The Standard for Clinicians’ Interview in Psychiatry (SCIP) was developed as a measurement-based care tool for clinicians’ use. The SCIP is the only instrument that includes 18 reliable and validated clinician-rated scales covering most adult psychiatric disorders. The SCIP has simple, unified rules of measurement that apply to the 18 scales. The MBC curriculum includes 2 instruction manuals, 4 didactic lectures, and 12 videotaped interviews. We describe the annual learning and implementation of MBC curriculum in residency programs.
Results
The curriculum implementation at West Virginia University and Delaware Psychiatric Center began in 2019 and is ongoing. We present 3 case demonstrations of the implementation of MBC in clinical settings.
Conclusions
Comprehensive implementation of MBC curriculum in residency programs has the potential to facilitate research and create a “culture” of MBC in future generations of psychiatrists.
Get full access to this article
View all access options for this article.
References
1.
WingJKBaborTBrughaTSCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry.1990;47(6)589–593.
2.
WHO: schedules for clinical assessment in neuropsychiatry interview.World Health Organization; 1999.
3.
WHO: schedules for clinical assessment in neuropsychiatry glossary.World Health Organization; 1998.
4.
SpitzerRLWilliamsJBGibbonMThe structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry.1992;49(8)624–629.
5.
WilliamsJBGibbonMFirstMBThe Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry.1992;49(8)630–636.
6.
SheehanDVLecrubierYSheehanKHThe Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry.1998;59 Suppl 20:22–33.
7.
AborayaAEl-MissiryABarloweJThe reliability of the Standard for Clinicians’ Interview in Psychiatry (SCIP): a clinician-administered tool with categorical, dimensional and numeric output. Schizophr Res.2014;156 (2-3):174–183.
8.
SpitzerRLKroenkeKWilliamsJB. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med.2006;166(10)1092–1097.
9.
KroenkeKSpitzerRLWilliamsJB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med.2002;64(2)258–266.
10.
KroenkeKSpitzerRLWilliamsJB. The PHQ-9: validity of a brief depression severity measure. J Gen Int Med.2001;16(9)606–613.
KaySRFiszbeinAOplerLA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull.1987;13(2)261–276.
14.
KaySROplerLAFiszbeinA.The positive and negative syndrome scale (PANSS) rating manual. Social and Behavioral Sciences Documents; 1987.
15.
FolsteinM FFolsteinSEMcHughPR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res.1975;12(3)189–198.
16.
McHughPR. Striving for coherence: psychiatry's efforts over classification. JAMA.2005;293(20)2526–2528.
17.
FindlingRLRobbAMcNamaraNKLithium in the acute treatment of bipolar I disorder: a double-blind, placebo-controlled study. Pediatrics.2015;136(5)885–894.
18.
RickelsKAmsterdamJClaryCA placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients. Acta Psychiatr Scand Suppl.1989; 350: 117–123.
19.
ElarabiHElrasheedAAliASuboxone treatment and recovery trial (STAR-T): study protocol for a randomised controlled trial of opioid medication assisted treatment with adjunctive medication management using therapeutic drug monitoring and contingency management. J Addict.2019; 2019: 2491063.
20.
KratochvilCJVaughanBSStonerJAA double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics.2011;127(4)e862–868.
21.
TaylorD PEisonMSRibletLAPharmacological and clinical effects of buspirone. Pharmacol Biochem Behav.1985 (4); 23: 687–694.
22.
TrivediMHRushAJWisniewskiSREvaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry.2006;163(1)28–40.
23.
FortneyJCUnützerJWrennGA tipping point for measurement-based care. Psychiatr Serv.2017; 68(2)179–188.
24.
AborayaANasrallahHAElswickDE Measurement-based care in psychiatry-past, present, and future. Innov Clin Neurosci. 2018;15 (11-12):13–26.
25.
RushAJ. Isn't it about time to employ measurement-based care in practice?Am J Psychiatry.2015;172(10)934–936.
26.
HardingKJRushAJArbuckleMMeasurement-based care in psychiatric practice: a policy framework for implementation. J Clin Psychiatry.2011;72(8)1136–1143.
27.
SapytaJRiemerMBickmanL.Feedback to clinicians: theory, research, and practice. J Clin Psychol.2005;61(2)145–153.
28.
KatonWJLinEH Von Korff M, Collaborative care for patients with depression and chronic illnesses. N Engl J Med.2010;363(27)2611–2620.
29.
HatfieldDMcCulloughLFrantzSHDo we know when our clients get worse? An investigation of therapists’ ability to detect negative client change. Clin Psychol Psychother.2010; 17: 25–32.
30.
Roy-ByrnePCraskeMGSullivanGDelivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA.2010;303(19)1921-1928.
31.
SimonGELudmanEJBauerMSLong-term effectiveness and cost of a systematic care program for bipolar disorder. Arch Gen Psychiatry.2006;63(5)500–508.
32.
BauerMSMcBrideLWillifordWO; Cooperative Studies Program 430 Study Team. Collaborative care for bipolar disorder: part II. Impact on clinical outcome, function, and costs. Psychiatr Serv.2006;57(7)937–945.
33.
HannanCLambertMJHarmonCA lab test and algorithms for identifying clients at risk for treatment failure. J Clin Psychol.2005;61(2)155–163.
34.
GuoTXiangY TXiaoLMeasurement-based care versus standard care for major depression: a randomized controlled trial with blind raters. Am J Psychiatry.2015;172(10)1004–1013.
35.
HatfieldDOglesB.Why some clinicians use outcome measures and others do not. Adm Policy Ment Health.2007;34(3)283–291.
36.
HatfieldDOglesB.The use of outcome measures by psychologists in clinical practice. Prof Psychol Res Pr.2004;35(5)485–491.
37.
ZimmermanMMcGlincheyJB. Why don't psychiatrists use scales to measure outcome when treating depressed patients?J Clin Psychiatry.2008;69(12) 1916-1919.
38.
NasrallahHA. Long overdue: measurement-based psychiatric practice. Curr Psychiatry.2009;8(4)14–16.
39.
ArbuckleMRWeinbergMHardingKJThe feasibility of standardized patient assessments as a best practice in an academic training program. Psychiatr Serv.2013;64(3)209–211.
40.
ScottKLewisCC. Using measurement-based care to enhance any treatment. Cogn Behav Pract.2015;22(1)49–59.
41.
ArbuckleMRWeinbergMKistlerSCA curriculum in measurement-based care: screening and monitoring of depression in a psychiatric resident clinic. Acad Psychiatry.2013;37(5)317–320.
42.
AborayaA.The validity results of the Standard for Clinicians’ Interview in Psychiatry (SCIP). Schizophr Bull.2015; 41: S103–S104.
43.
AborayaA.Instruction manual for the Standard for Clinicians’ Interview in Psychiatry (SCIP). Innov Clin Neurosci.2016;13 (5-6):41–77.
44.
AborayaANasrallahHMuvvalaSThe Standard for Clinicians’ Interview in Psychiatry (SCIP): a clinician-administered tool with categorical, dimensional, and numeric output–conceptual development, design, and description of the SCIP. Innov Clin Neurosci.2016;13 (5-6):31–77.
45.
AborayaANasrallahHA. Perspectives on the Positive and Negative Syndrome Scale (PANSS): use, misuse, drawbacks, and a new alternative for schizophrenia research. Ann Clin Psychiatry.2016; 28(2)125–131.
46.
MoranPLeeseMLeeTStandardised Assessment of Personality - Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder. Br J Psychiatry.2003; 183: 228–232.
47.
LiWYangYLiuZHProgression of mental health services during the COVID-19 outbreak in China. Int J Biol Sci.2020;16(10)1732–1738.
48.
HoCSCheeCYHoRC. Mental health strategies to combat the psychological impact of COVID-19 beyond paranoia and panic. Ann Acad Med Singapore.2020;49(3)155–160.
49.
XiangY TYangYLiWTimely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry.2020;7(3)228–229.
50.
KalinMLGarlowSJThertusKRapid implementation of telehealth in hospital psychiatry in response to COVID-19. Am J Psychiatry.2020;177(7)636–637.
51.
WellsMMitchellKJFinkelhorDOnline mental health treatment: concerns and considerations. Cyberpsychol Behav.2007;10(3)453–459.
52.
PerleJBurtJHigginsW.Psychologist and physician interest in telehealth training and referral for mental health services: an exploratory study. J Technol Hum Serv.2014;32(3)158–185.
53.
PierceBPerrinPMcDonaldS.Demographic, organizational, and clinical practice predictors of US psychologists’ use of telepsychology. Prof Psychol Res Pr.2020;51(2)184–193.
